This press release is intended for US Media

本新闻稿面向美国媒体

EpiCypher’s new bioinformatics platform, powered by DNAnexus, accelerates data analysis for leading chromatin mapping technologies including CUT&RUN and CUT&Tag.

EpiCypher推出的由DNAnexus支持的全新生物信息学平台，加速了包括CUT&RUN和CUT&Tag在内的领先染色质图谱技术的数据分析。

DURHAM, N.C., November 10, 2025  /

北卡罗来纳州达勒姆，2025年11月10日 /

Biotech Newswire

生物科技新闻专线

/ --

/ --

EpiCypher®

EpiCypher®

, a pioneer in chromatin mapping technologies and reagents and the leading manufacturer of CUT&RUN and CUT&Tag assays, today announced the launch of

，染色质图谱技术和试剂的先驱，同时也是CUT&RUN和CUT&Tag检测的领先制造商，今天宣布推出

CUTANA

卡塔纳

®

®

Cloud

云

, a secure, user-friendly bioinformatics platform designed to streamline analysis of high-throughput chromatin mapping assays such as

，一个安全、用户友好的生物信息学平台，旨在简化高通量染色质图谱分析等工作流程，例如

CUT&RUN

CUT&RUN

and

和

CUT&Tag,

CUT&Tag，

as well as future applications such as

以及未来应用，例如

ATAC-seq

ATAC-seq

. As a platform that democratizes access to state-of-the-art pipelines for chromatin profiling analysis,

作为一个平台，它使人们能够民主地获取用于染色质分析的最先进的流程，

CUTANA® Cloud

CUTANA® 云

enables biologists to rapidly process data from these assays without the need for advanced computational expertise.

使生物学家能够快速处理这些测定的数据，而无需具备高级计算专业知识。

CUTANA® Cloud is currently available in the US only.

CUTANA® Cloud 目前仅在美国可用。

Empowering Biologists with Fast, Accessible Epigenomic Analysis

快速、便捷的表观基因组分析赋能生物学家

Epigenomics helps researchers understand why genes turn on or off, the key to unlocking how cells function, respond to their environment, and drive disease. By mapping the chemical and structural changes that shape chromatin, such as histone modifications and transcription factor binding, epigenomic research reveals the regulatory mechanisms controlling gene expression.

表观基因组学帮助研究人员理解基因为何开启或关闭，这是解锁细胞功能、对环境的反应以及驱动疾病的关键。通过绘制塑造染色质的化学和结构变化图谱，例如组蛋白修饰和转录因子结合，表观基因组学研究揭示了控制基因表达的调控机制。

These insights are transforming biomedical science, fueling the discovery of new drug targets, biomarkers, and precision treatment strategies..

这些见解正在转变生物医学科学，推动新的药物靶点、生物标志物和精准治疗策略的发现。

Built on the

建立在

DNAnexus

DNAnexus

precision health platform, EpiCypher’s

精准健康平台，EpiCypher的

CUTANA® platform

CUTANA® 平台

provides access to scalable compute resources in an environment with enterprise-grade security. Together, EpiCypher and DNAnexus are working to empower biologists to step out of the months-long bioinformatics queue and independently move from sequencing data to actionable biological insights in hours – .

提供了在企业级安全环境中访问可扩展计算资源的能力。EpiCypher 和 DNAnexus 携手合作，助力生物学家摆脱长达数月的生物信息学队列，独立地在数小时内从测序数据获得可操作的生物学见解。

accelerating breakthroughs in fundamental research and drug development

加速基础研究和药物开发的突破性进展

.

。

“EpiCypher is proud to offer CUTANA® Cloud to chromatin and genomic researchers nationwide,”

“EpiCypher 很自豪能为全国的染色质和基因组研究人员提供 CUTANA® Cloud，”

said Keith Maier, Associate Director of Product Development at EpiCypher.

EpiCypher产品开发副总监Keith Maier表示。

“With its intuitive, cloud-based chromatin profiling analysis workflows, wet-lab researchers can rapidly complete secondary analysis and assess experimental success without waiting weeks to months for bioinformatic support.”

“通过其直观的、基于云的染色质分析工作流程，湿实验室研究人员可以快速完成二次分析并评估实验成功与否，而无需等待数周到数月的生物信息学支持。”

DNAnexus currently supports more than 60,000 registered users across 48 countries and actively manages more than 125 petabytes of complex clinical, genomic, proteomic, and other multiomic datasets on behalf of a growing network of collaborators. DNAnexus’ comprehensive platform meets the most rigorous industry standards for precision health data quality, security, privacy, and regulatory compliance..

DNAnexus目前在48个国家拥有超过60,000名注册用户，并代表不断扩展的合作者网络，积极管理着超过125PB的复杂临床、基因组、蛋白质组学及其他多组学数据集。DNAnexus的综合平台符合精准健康数据质量、安全性、隐私和法规遵从性的最高行业标准。

“Our collaboration with EpiCypher exemplifies the DNAnexus commitment to working closely with our partners to pioneer new innovations and transform life sciences,”

“我们与EpiCypher的合作体现了DNAnexus致力于与合作伙伴紧密合作，开拓创新并转变生命科学的承诺。”

said Kristy Cloyd-Warwick, SVP, Customer Experience at DNAnexus.

DNAnexus客户体验高级副总裁克里斯蒂·克洛伊德-沃里克表示。

“Together, we’re empowering researchers to explore the epigenetic mechanisms that control gene regulation, and to turn those discoveries into better treatments and improved patient outcomes.”

“我们共同赋予研究人员探索控制基因调控的表观遗传机制的能力，并将这些发现转化为更好的治疗方法和改善患者的预后。”

About

关于

EpiCypher

EpiCypher

EpiCypher was founded in response to the growing demand for high-quality reagents to study chromatin regulation and enable epigenetics-focused drug discovery. The company is at the forefront of chromatin mapping technologies with the CUTANA® platform for ultra-sensitive CUT&RUN, CUT&Tag, Fiber-seq and DNA methylation profiling assays.

EpiCypher 公司因应市场对高质量试剂日益增长的需求而成立，致力于研究染色质调控并推动以表观遗传学为重点的药物发现。该公司处于染色质图谱技术的前沿，拥有用于超灵敏 CUT&RUN、CUT&Tag、Fiber-seq 和 DNA 甲基化分析的 CUTANA® 平台。

EpiCypher also offers the largest collection of defined designer nucleosomes (dNucs) on the market along with complementary high-throughput assays and services. EpiCypher is dedicated to bringing these transformative technologies to market and offers superior products and assay services to researchers worldwide. .

EpiCypher 还提供市场上种类最全的定制设计核小体 (dNucs)，以及配套的高通量检测和服务。EpiCypher 致力于将这些变革性技术推向市场，为全球研究人员提供卓越的产品和检测服务。

EpiCypher and CUTANA are registered trademarks of EpiCypher, Inc.

EpiCypher 和 CUTANA 是 EpiCypher, Inc. 的注册商标。

About

关于

DNAnexus

DNAnexus

DNAnexus, the enterprise platform for precision health data, is on a mission to accelerate the development, approval, and delivery of personalized treatments. Building on more than 15 years of bioinformatics innovation and genomics expertise, DNAnexus powers a connected data ecosystem trusted by the world’s precision health leaders.

DNAnexus，精准健康数据的企业平台，致力于加速个性化治疗的开发、审批和交付。基于超过15年的生物信息学创新和基因组学专业知识，DNAnexus构建了一个互联的数据生态系统，受到全球精准健康领域领导者的信赖。

This flexible ecosystem makes omics and real-world data accessible, actionable, and secure while unlocking insights that improve patient lives. For more information, visit .

这一灵活的生态系统可使组学和真实世界的数据易于获取、可操作且安全，同时释放改善患者生活的洞察力。欲了解更多信息，请访问。

www.dnanexus.com

www.dnanexus.com

or follow @DNAnexus on social media.

或在社交媒体上关注 @DNAnexus。

Contact

联系

EpiCypher

EpiCypher

Janna Badalian

扬娜·巴达良

919-520-9792

919-520-9792

This email address is being protected from spambots. You need JavaScript enabled to view it.

该电子邮件地址正受到垃圾邮件程序的保护。您需要启用 JavaScript 才能查看它。

Keywords: Chromatin; Epigenomics; Histone Code; Gene Expression; Drug Discovery; EpiCypher; CUTANA® Cloud; epigenomic data analysis; bioinformatics platform; DNAnexus; chromatin mapping; CUT&RUN; CUT&Tag; ATAC-seq; chromatin profiling analysis; histone modifications; transcription factor binding; regulatory mechanisms; drug targets; biomarkers; chromatin researchers; genomic researchers; cloud-based workflows; data quality; regulatory compliance; epigenetic mechanisms; gene regulation; chromatin regulation; epigenetics-focused drug discovery; DNA methylation profiling; assay services; reagents; North America.

关键词：染色质；表观基因组学；组蛋白密码；基因表达；药物发现；EpiCypher；CUTANA® Cloud；表观基因组数据分析；生物信息学平台；DNAnexus；染色质图谱；CUT&RUN；CUT&Tag；ATAC-seq；染色质分析；组蛋白修饰；转录因子结合；调控机制；药物靶点；生物标志物；染色质研究者；基因组研究者；基于云的工作流程；数据质量；法规合规；表观遗传机制；基因调控；染色质调控；表观遗传学导向的药物发现；DNA甲基化分析；检测服务；试剂；北美。

Source: Biotech Newswire

来源：生物技术新闻社